Gene therapy goes acoustic as ARCH-backed biotech launches with ultrasound gene delivery platform
Nkarta underscores safety of CAR-NK, boasts early responses
The Era of One-Shot, Multimillion-Dollar Genetic Cures Is Here
Gene therapies promise long-term relief from intractable diseases—if insurers agree to pony up.
Abandoned - The human cost of neurotechnology failure
When the makers of electronic implants abandon their projects, people who rely on the devices have everything to lose.
BioCardia's off-the-shelf cell therapy for heart failure to enter first-in-human study
DeepMind AI topples experts at complex game Stratego
Game-playing AIs that interact with humans are laying important groundwork for real-world applications.
Researchers welcome $3.5-million haemophilia gene therapy — but questions remain
The world’s most expensive drug has the potential to save lives. But it cannot treat the most common form of the disease.
What Causes Alzheimer’s? Scientists Are Rethinking the Answer.
After decades in the shadow of the reigning model for Alzheimer’s disease, alternative explanations are finally getting the attention they deserve.
The therapeutic potential of psychedelics
The development of psychedelics as medicines faces several challenges
Decoding CAR T cell phenotype using combinatorial signalling motif libraries and machine learning
Gilead buys into multiple myeloma cell therapy with Arcellx deal